Analyst firms · Susquehanna · RXO

Susquehanna RXO price target and rating history

RXO Inc. (RXO) · Consumer Discretionary

Susquehanna rates RXO Inc. (RXO) Neutral with a $19 price target, as of its latest action on Sep 23, 2026. It has published 3 rating actions on RXO since June 2023, including 1 upgrade and 1 downgrade. Across 6 firms with a RXO price target in the last 12 months, the median target is $22. Susquehanna's $19 is 14% below that.

Current rating
Neutral
Price target
$19
Median target, all firms
$22
Actions on RXO
3

Susquehanna price target on RXO

$20$17$14202420252026
Susquehanna price target on RXO, each point a stated target, June 2023 to September 2026.

Every Susquehanna rating on RXO

How other firms rate RXO

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Citizens JMPMkt Perform$30Oct 15, 2026
SusquehannaNeutral$19Sep 23, 2026
TD CowenSell$17.50Aug 7, 2026
BMO Capital MarketsOutperform$35Jul 14, 2026
StifelBuy$22May 15, 2026
Morgan StanleyEqual-Weight$22May 8, 2026

Questions about Susquehanna and RXO

What is Susquehanna's price target for RXO?
Susquehanna's latest stated price target for RXO Inc. (RXO) is $19, from its action on Sep 23, 2026.
What is Susquehanna's rating on RXO?
Susquehanna rates RXO Neutral, a neutral rating, as of Sep 23, 2026.
When did Susquehanna last change its view on RXO?
On Sep 23, 2026, Susquehanna upgrades to Neutral from Negative, price target $19.
How does Susquehanna's RXO target compare with other analysts?
Across 6 firms with a RXO price target in the last 12 months, the median target is $22. Susquehanna's $19 is 14% below that.

More RXO rating histories

All Susquehanna ratingsRXO news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.